Occidental Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Sell
9,853
-207
-2% -$5.51K 0.03% 225
2025
Q4
$250K Sell
10,060
-1,172
-10% -$29.6K 0.03% 233
2025
Q3
$286K Buy
+11,232
New +$277K 0.04% 209
2025
Q2
Sell
-9,360
Closed -$237K 279
2025
Q1
$237K Sell
9,360
-567
-6% -$14.8K 0.04% 221
2024
Q4
$263K Sell
9,927
-3,847
-28% -$104K 0.04% 177
2024
Q3
$399K Buy
13,774
+544
+4% +$15.9K 0.06% 154
2024
Q2
$370K Buy
13,230
+2,627
+25% +$72.3K 0.07% 149
2024
Q1
$294K Sell
10,603
-94
-0.9% -$2.61K 0.06% 160
2023
Q4
$308K Sell
10,697
-642
-6% -$19.4K 0.06% 165
2023
Q3
$376K Sell
11,339
-21
-0.2% -$743 0.09% 149
2023
Q2
$417K Sell
11,360
-28,153
-71% -$1.1M 0.09% 159
2023
Q1
$1.61M Buy
39,513
+3,452
+10% +$149K 0.4% 77
2022
Q4
$1.85M Buy
36,061
+2,371
+7% +$114K 0.5% 59
2022
Q3
$1.47M Buy
33,690
+3,240
+11% +$157K 0.44% 67
2022
Q2
$1.6M Buy
30,450
+2,618
+9% +$133K 0.47% 58
2022
Q1
$1.44M Buy
27,832
+16,850
+153% +$874K 0.37% 75
2021
Q4
$648K Buy
10,982
+592
+6% +$29.3K 0.15% 132
2021
Q3
$447K Buy
10,390
+242
+2% +$10.7K 0.12% 146
2021
Q2
$397K Hold
10,148
0.11% 155
2021
Q1
$368K Buy
10,148
+21
+0.2% +$746 0.11% 151
2020
Q4
$373K Buy
10,127
+1,407
+16% +$51.6K 0.12% 137
2020
Q3
$304K Hold
8,720
0.13% 118
2020
Q2
$271K Sell
8,720
-632
-7% -$21.5K 0.12% 126
2020
Q1
$290K Sell
9,352
-1,427
-13% -$48.6K 0.15% 116
2019
Q4
$401K Hold
10,779
0.16% 119
2019
Q3
$367K Hold
10,779
0.15% 120
2019
Q2
$443K Hold
10,779
0.2% 105
2019
Q1
$434K Hold
10,779
0.21% 102
2018
Q4
$446K Hold
10,779
0.25% 77
2018
Q3
$451K Hold
10,779
0.23% 89
2018
Q2
$371K Sell
10,779
-743
-6% -$25.4K 0.2% 99
2018
Q1
$388K Hold
11,522
0.21% 92
2017
Q4
$396K Hold
11,522
0.21% 88
2017
Q3
$390K Hold
11,522
0.22% 80
2017
Q2
$367K Buy
11,522
+376
+3% +$11.9K 0.22% 81
2017
Q1
$362K Hold
11,146
0.24% 75
2016
Q4
$343K Buy
11,146
+738
+7% +$22.5K 0.25% 78
2016
Q3
$334K Hold
10,408
0.27% 70
2016
Q2
$348K Buy
10,408
+2,059
+25% +$65.7K 0.3% 65
2016
Q1
$235K Hold
8,349
0.28% 64
2015
Q4
$256K Hold
8,349
0.33% 58
2015
Q3
$234K Hold
8,349
0.33% 58
2015
Q2
$235K Hold
8,349
0.32% 57
2015
Q1
$254K Hold
8,349
0.32% 55
2014
Q4
$243K Sell
8,349
-8,569
-51% -$246K 0.37% 55
2014
Q3
$461K Sell
16,918
-3,214
-16% -$90.2K 0.75% 32
2014
Q2
$535K Sell
20,132
-762
-4% -$21.7K 0.92% 27
2014
Q1
$572K Buy
+20,894
New +$623K 1.02% 22

Other funds holding PFE

Occidental Asset Management's PFE Position: Q1 2026 in Review

Occidental Asset Management reduced its Pfizer (PFE) stake by 2.1% in Q1 2026, selling an estimated $5.51K and leaving 9,853 shares worth $277K. The position accounts for 0.03% of the portfolio, ranked #225.

Occidental Asset Management first reported a position in PFE in Q1 2014 and has held it in 48 quarters since. The position peaked at $1.85M in Q4 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Occidental Asset Management held 9,853 shares of Pfizer worth $277K as of Q1 2026.
  • Occidental Asset Management sold 207 Pfizer shares in Q1 2026, an estimated $5.51K.
  • Pfizer made up 0.03% of Occidental Asset Management's portfolio in Q1 2026, its #225 holding.
  • Occidental Asset Management first reported a position in Pfizer in Q1 2014 and has held it in 48 quarters since.
  • Occidental Asset Management's Pfizer position peaked at $1.85M in Q4 2022.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Occidental Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.